Related references
Note: Only part of the references are listed.Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2
Jie Lv et al.
CANCER LETTERS (2020)
Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
Long Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma
Yue Shi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Inhibition of PSMD4 blocks the tumorigenesis of hepatocellular carcinoma
Mei-Juan Cai et al.
GENE (2019)
POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1
Boshi Wang et al.
EBIOMEDICINE (2019)
Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma
Lorenza Rimassa et al.
CANCER TREATMENT REVIEWS (2019)
PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism
Yanjie Tan et al.
BMC MOLECULAR BIOLOGY (2019)
Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma
Guofen Zeng et al.
ONCOTARGETS AND THERAPY (2019)
The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway
Dongyeob Seo et al.
EBIOMEDICINE (2019)
DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
Junyu Long et al.
THERANOSTICS (2019)
Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma
Rui Zhu et al.
CANCER LETTERS (2018)
POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity
Li Zhang et al.
NATURE COMMUNICATIONS (2018)
RPN11 deubiquitinase promotes proliferation and migration of breast cancer cells
Guoqing Luo et al.
MOLECULAR MEDICINE REPORTS (2017)
Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance
Y. Song et al.
ONCOGENE (2017)
Generation of CD8+ T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy
Sandra Hoefflin et al.
CANCER BIOLOGY & THERAPY (2015)
POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation
Boshi Wang et al.
NATURE COMMUNICATIONS (2015)
The proteasomal de-ubiquitinating enzyme POH1 promotes the double-strand DNA break response
Laura R. Butler et al.
EMBO JOURNAL (2012)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence
Ann Byrne et al.
EXPERIMENTAL CELL RESEARCH (2010)
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach et al.
HEPATOLOGY (2007)
Gene expression patterns in human liver cancers
X Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Share Paper
